These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
465 related articles for article (PubMed ID: 27003573)
1. Transfemoral Aortic Valve Implantation with the New Edwards Sapien 3 Valve for Treatment of Severe Aortic Stenosis-Impact of Valve Size in a Single Center Experience. Wöhrle J; Gonska B; Rodewald C; Seeger J; Scharnbeck D; Rottbauer W PLoS One; 2016; 11(3):e0151247. PubMed ID: 27003573 [TBL] [Abstract][Full Text] [Related]
3. Transfemoral aortic valve implantation is more successful with the Edwards Sapien 3 compared with the Edwards XT for the treatment of symptomatic severe aortic stenosis. Gonska B; Seeger J; Junker A; Rodewald C; Trepte U; Scharnbeck D; Rottbauer W; Wöhrle J Arch Cardiovasc Dis; 2018; 111(8-9):470-479. PubMed ID: 29128473 [TBL] [Abstract][Full Text] [Related]
4. Computed Tomography-Based Oversizing Degrees and Incidence of Paravalvular Regurgitation of a New Generation Transcatheter Heart Valve. Blanke P; Pibarot P; Hahn R; Weissman N; Kodali S; Thourani V; Parvataneni R; Dvir D; Naoum C; Nørgaard BL; Douglas P; Jaber W; Khalique OK; Jilaihawi H; Mack M; Smith C; Leon M; Webb J; Leipsic J JACC Cardiovasc Interv; 2017 Apr; 10(8):810-820. PubMed ID: 28427598 [TBL] [Abstract][Full Text] [Related]
5. A prospective "oversizing" strategy of the Edwards SAPIEN bioprosthesis: results and impact on aortic regurgitation. Samim M; Stella PR; Agostoni P; Kluin J; Ramjankhan F; Sieswerda G; Budde R; van der Linden M; Juthier F; Banfi C; Hurt C; Samim M; Hillaert M; van Herwerden L; Bertrand ME; Doevendans PA; Van Belle E J Thorac Cardiovasc Surg; 2013 Feb; 145(2):398-405. PubMed ID: 22377664 [TBL] [Abstract][Full Text] [Related]
6. Device success and 30-day clinical outcome in patients undergoing preimplant valvuloplasty in transfemoral versus omitting valvuloplasty in transapical transcatheter aortic valve replacement. Wong SC; Pawar S; Minutello RM; Horn EM; Skubas NJ; Devereux RB; Salemi A J Thorac Cardiovasc Surg; 2015 Nov; 150(5):1111-7. PubMed ID: 26277463 [TBL] [Abstract][Full Text] [Related]
7. Transfemoral aortic valve implantation with the repositionable Lotus valve compared with the balloon-expandable Edwards Sapien 3 valve. Wöhrle J; Gonska B; Rodewald C; Trepte U; Koch S; Scharnbeck D; Seeger J; Markovic S; Rottbauer W Int J Cardiol; 2015 Sep; 195():171-5. PubMed ID: 26043152 [TBL] [Abstract][Full Text] [Related]
8. Transfemoral aortic valve replacement with the Edwards SAPIEN and Edwards SAPIEN XT prosthesis using exclusively local anesthesia and fluoroscopic guidance: feasibility and 30-day outcomes. Durand E; Borz B; Godin M; Tron C; Litzler PY; Bessou JP; Bejar K; Fraccaro C; Sanchez-Giron C; Dacher JN; Bauer F; Cribier A; Eltchaninoff H JACC Cardiovasc Interv; 2012 May; 5(5):461-467. PubMed ID: 22560979 [TBL] [Abstract][Full Text] [Related]
9. European experience with the second-generation Edwards SAPIEN XT transcatheter heart valve in patients with severe aortic stenosis: 1-year outcomes from the SOURCE XT Registry. Schymik G; Lefèvre T; Bartorelli AL; Rubino P; Treede H; Walther T; Baumgartner H; Windecker S; Wendler O; Urban P; Mandinov L; Thomas M; Vahanian A JACC Cardiovasc Interv; 2015 Apr; 8(5):657-69. PubMed ID: 25946437 [TBL] [Abstract][Full Text] [Related]
10. Early clinical outcome of aortic transcatheter valve-in-valve implantation in the Nordic countries. Ihlberg L; Nissen H; Nielsen NE; Rück A; Busund R; Klaarborg KE; Soendergaard L; Harnek J; Miettinen H; Eskola M; Wahba A; Laine M J Thorac Cardiovasc Surg; 2013 Nov; 146(5):1047-54; discussion 1054. PubMed ID: 23998786 [TBL] [Abstract][Full Text] [Related]
11. Clinical outcome and paravalvular leakage of the new balloon-expandable Edwards Sapien 3 valve in comparison to its predecessor model (Edwards Sapien XT) in patients undergoing transfemoral aortic valve replacement. Bocksch W; Grossmann B; Geisler T; Steeg M; Droppa M; Jorbenadze R; Haap M; Gawaz M; Fateh-Moghadam S Catheter Cardiovasc Interv; 2016 Sep; 88(3):466-75. PubMed ID: 27184353 [TBL] [Abstract][Full Text] [Related]
12. Multicenter evaluation of a next-generation balloon-expandable transcatheter aortic valve. Webb J; Gerosa G; Lefèvre T; Leipsic J; Spence M; Thomas M; Thielmann M; Treede H; Wendler O; Walther T J Am Coll Cardiol; 2014 Dec; 64(21):2235-43. PubMed ID: 25456759 [TBL] [Abstract][Full Text] [Related]
13. Outcomes after transcatheter aortic valve implantation with both Edwards-SAPIEN and CoreValve devices in a single center: the Milan experience. Godino C; Maisano F; Montorfano M; Latib A; Chieffo A; Michev I; Al-Lamee R; Bande M; Mussardo M; Arioli F; Ielasi A; Cioni M; Taramasso M; Arendar I; Grimaldi A; Spagnolo P; Zangrillo A; La Canna G; Alfieri O; Colombo A JACC Cardiovasc Interv; 2010 Nov; 3(11):1110-21. PubMed ID: 21087745 [TBL] [Abstract][Full Text] [Related]
14. The balloon-expandable Edwards Sapien 3 valve is superior to the self-expanding Medtronic CoreValve in patients with severe aortic stenosis undergoing transfemoral aortic valve implantation. Gonska B; Seeger J; Baarts J; Rodewald C; Scharnbeck D; Rottbauer W; Wöhrle J J Cardiol; 2017 Jun; 69(6):877-882. PubMed ID: 27614379 [TBL] [Abstract][Full Text] [Related]
15. Outcome With the Repositionable and Retrievable Boston Scientific Lotus Valve Compared With the Balloon-Expandable Edwards Sapien 3 Valve in Patients Undergoing Transfemoral Aortic Valve Replacement. Seeger J; Gonska B; Rottbauer W; Wöhrle J Circ Cardiovasc Interv; 2017 Jun; 10(6):. PubMed ID: 28566290 [TBL] [Abstract][Full Text] [Related]
16. Management of paravalvular regurgitation after Edwards SAPIEN transcatheter aortic valve replacement: management of paravalvular regurgitation after TAVR. Martinez CA; Singh V; O'Neill BP; Alfonso CE; Bilsker MS; Martinez Clark P; Williams D; Cohen MG; Heldman AW; O'Neill WW Catheter Cardiovasc Interv; 2013 Aug; 82(2):300-11. PubMed ID: 23580318 [TBL] [Abstract][Full Text] [Related]
17. Incidence and severity of paravalvular aortic regurgitation with multidetector computed tomography nominal area oversizing or undersizing after transcatheter heart valve replacement with the Sapien 3: a comparison with the Sapien XT. Yang TH; Webb JG; Blanke P; Dvir D; Hansson NC; Nørgaard BL; Thompson CR; Thomas M; Wendler O; Vahanian A; Himbert D; Kodali SK; Hahn RT; Thourani VH; Schymik G; Precious B; Berger A; Wood DA; Pibarot P; Rodés-Cabau J; Jaber WA; Leon MB; Walther T; Leipsic J JACC Cardiovasc Interv; 2015 Mar; 8(3):462-471. PubMed ID: 25790764 [TBL] [Abstract][Full Text] [Related]
18. Transfemoral implantation of Edwards Sapien XT aortic valve without previous valvuloplasty: role of 2D/3D transesophageal echocardiography. García E; Almería C; Unzué L; Jiménez-Quevedo P; Cuadrado A; Macaya C Catheter Cardiovasc Interv; 2014 Nov; 84(6):868-76. PubMed ID: 24482054 [TBL] [Abstract][Full Text] [Related]
19. New generation devices for transfemoral transcatheter aortic valve replacement are superior compared with last generation devices with respect to VARC-2 outcome. Seeger J; Gonska B; Rottbauer W; Wöhrle J Cardiovasc Interv Ther; 2018 Jul; 33(3):247-255. PubMed ID: 28643214 [TBL] [Abstract][Full Text] [Related]
20. Transfemoral aortic valve implantation with the repositionable Lotus valve for treatment of patients with symptomatic severe aortic stenosis: results from a single-centre experience. Wöhrle J; Gonska B; Rodewald C; Seeger J; Scharnbeck D; Rottbauer W EuroIntervention; 2016 Aug; 12(6):760-7. PubMed ID: 27542789 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]